| Excerpt | Relevance | Reference |
|---|
| "In this single-blind, controlled trial, consecutively hospitalized elderly patients (age > or = 70 years) with inflammation (C-reactive protein [CRP] levels > or =10 mg/L) due to acute infection were randomly assigned to receive 2 weeks of treatment with the COX-2-selective inhibitor celecoxib, acetaminophen, or no supplementary medication (control)." | 9.11 | The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation. ( Bautmans, I; Demanet, C; Lambert, M; Mets, T; Njemini, R, 2004) |
| "In this single-blind, controlled trial, consecutively hospitalized elderly patients (age > or = 70 years) with inflammation (C-reactive protein [CRP] levels > or =10 mg/L) due to acute infection were randomly assigned to receive 2 weeks of treatment with the COX-2-selective inhibitor celecoxib, acetaminophen, or no supplementary medication (control)." | 5.11 | The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation. ( Bautmans, I; Demanet, C; Lambert, M; Mets, T; Njemini, R, 2004) |